Technology | 2009.10.15
TheraDoc Announces New Surveillance Tool to Track MRSA and Other Potent Multidrug-Resistant Infectious Diseases
SALT LAKE CITY--(BUSINESS WIRE)--TheraDoc®, the leading provider of clinical decision support technology in healthcare, today announced that it has started beta testing of a new computerized patient surveillance tool that will help hospitals monitor and manage screening programs for multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills more people in the United States than AIDS. The MDRO Compliance Manager, designed for u
For more information, please visit
http://www.businesswire.com/news/home/20091015005248/en
